Search

everythinglearnresearchcommunity

for

Search:↓

A group has developed therapies that show promise for treating cancer and various other conditions.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Mutant mice help researchers understand hair growth and related genetic factors.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

Taxol damages hair growth cells, causing hair loss.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Long-COVID has diverse, long-term health impacts, especially in young people.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.